TMCnet News
Research and Markets: Global Cytomegalovirus Retinitis Market Report 2014 - Forecasts to 2018DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/xb6mrt/global) has announced the addition of the "Global Cytomegalovirus Retinitis Market 2014-2018" report to their offering. The Global Cytomegalovirus Retinitis market to grow at a CAGR of 4.50 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Cytomegalovirus Retinitis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various branded and generic drugs used for the treatment of cytomegalovirus retinitis. Capsules, implants, solutions, and tablets are the four dosage forms of the drugs used for the treatment of cytomegalovirus retinitis. An inrease in combination therapies for the treatment of cytomegalovirus retinitis is a major trend emerging in the market. These therapies lower drug resistance in patients and ensure more effective action of the drug. According to the report, the Global Cytomegalovirus Retinitis market is experiencing a large number of unmet needs. Currently, Roche's Valcyte is the only branded drug available for the treatment of this indication. The market has also observed the use of off-label drugs for the treatment of cytomegalovirus retinitis. Further, the report states that one of the major challenges in the market is a lack of approved treatment guidelines by the WHO, which is responsible for the negligence of the treatment of cytomegalovirus retinitis worldwide. Key Questions Answered in this Report
Key Vendors
Other Prominent Vendors
For more information visit http://www.researchandmarkets.com/research/xb6mrt/global
|
